Thermo Fisher 9 nov 2025 Thermo Fisher Scientific (TMO): Evaluating Valuation After $5 Billion Share Buyback Announcement - simplywall.st #Fisher Scientific #Evaluating Valuation
10x Genomics Blog 7 nov 2025 Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq #Overweight Recommendation #Barclays Maintains
10x Genomics Blog 7 nov 2025 JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq #Morgan Maintains #Neutral Recommendation
Agilent 5 nov 2025 Is Agilent Technologies, Inc.'s (NYSE:A) Recent Stock Performance Tethered To Its Strong Fundamentals? - Yahoo Finance #Agilent Technologies #Recent Stock
Waters 4 nov 2025 Waters Corporation (WAT) Slipped Following the Acquisition Announcement - Insider Monkey #Waters Corporation #Acquisition Announcement
Illumina 1 nov 2025 Barclays Maintains Illumina (ILMN) Underweight Recommendation - Nasdaq #Maintains Illumina #Underweight Recommendation
Lonza News 30 oct 2025 Can Mixed Fundamentals Have A Negative Impact on Lonza Group AG (VTX:LONN) Current Share Price Momentum? - Yahoo Finance #Current Share #Price Momentum
Thermo Fisher 27 oct 2025 Thermo Fisher Scientific Showcases Enhanced Accelerator™ Drug Development Capabilities and OpenAI Strategic Collaboration at CPHI Frankfurt 2025 - Business Wire #Enhanced Accelerator #Drug Development
Lonza News 23 oct 2025 Lonza confirms "long-term commercial supply agreement" at U.S. biologic drug site - Investing.com #Lonza confirms #long-term commercial
Promega Blog 22 oct 2025 Compact Design, Big Impact: Tridek-One Therapeutics Leverages MyGlo® to Accelerate Discovery of Immunomodulating Treatments #Reagent Reader #Big Impact
Thermo Fisher 17 oct 2025 What Thermo Fisher Scientific (TMO)'s OpenAI Partnership Could Mean for Drug Development Innovation - Yahoo Finance #Fisher Scientific #Thermo Fisher
Lonza News 16 oct 2025 Lonza Capsugel launches organic, vegan capsule line - SupplySide Supplement Journal #Supplement Journal #Lonza Capsugel
Lonza News 10 oct 2025 Is Now An Opportune Moment To Examine Lonza Group AG (VTX:LONN)? - Yahoo Finance #Opportune Moment #Examine Lonza
Lonza News 6 oct 2025 Lonza Expands TheraPEAK® Portfolio to Strengthen Support for Gene and Cell Therapy Development - Lab Manager #Strengthen Support #Cell Therapy
Lonza News 26 sept 2025 Lonza’s Synaffix Collaborates with Qurient Therapeutics on Dual-Payload ADC Development - GEN - Genetic Engineering and Biotechnology News #Genetic Engineering #Synaffix Collaborates
Roche Media 26 sept 2025 Roche, Novartis underline U.S. plans after Trump pharma tariff announcement - Reuters #Novartis underline #Trump pharma
Lonza News 25 sept 2025 Lonza's Synaffix Collaborates with Qurient Therapeutics to Enable Development of Dual-Payload ADC - Yahoo Finance #Synaffix Collaborates #Qurient Therapeutics
Roche Media 25 sept 2025 Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial - CNBC #obesity player #Roche targets